تصویر

Seyed Massood Nabavi    MD
Regenerative Medicine
Professor

Email:sm.nabavi@Royaninstitute.org
Tel:+989121309304
Fax:
CV:Prof. SM Nabavi. CV.pdf

Neurological diseases, MS and neuroimmunology, regenerative medicine
Compiling of 5 books in Farsi (Persian language):  MS ,symptomatic management for the patients, 2006 and revised in 2021  The origins and development of Neurology for professionals, 2004  Exercise and training in MS, 2013  The guide to treatment and management of MS, 2001 (Translating from English to Farsi) Publication of more than 100 Abstracts (in English and Farsi) and publication of more than 250 full text articles (in English and Farsi). Some of the published articles are as follows:  Sex hormone therapy in Multiple Sclerosis: A systematic review of randomized clinical trials. M Shayestehfar, M Salari, S Karimi, M Vosough, A Memari, SM Nabavi. Journal of Central Nervous System Disease, 2024  Pathogenic α‐synuclein triggers focal tau pathology, developing to various brain areas in Parkinson disease. F Hadi, K Shahpasand, H Akrami, M Totonchi, A Barzegar, SM Nabavi. Alzheimer's & Dementia, 2023  Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments. F Foolad, Z Samadi Bahrami, F Khodagholi, SM Nabavi, GR Moore, et al. Molecular Neurobiology, 2023  Horizons of MS therapy: during 30 years (ORP-06). SM Nabavi. Neurology Letters, 2023  Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study. SM Nabavi, S Karimi, L Arab, N Aghdami, N Joghtaei, S Maroufizadeh, et al. Multiple Sclerosis and Related Disorders, 2023  Pathogenic α-synuclein triggers focal tau pathology, developing to various brain areas in Parkinson disease. F Hadi, K Shahpasand, H Akrami, M Totonchi, A Barzegar, SM Nabavi. Alzheimer's Association International Conference, 2023  A case–control study of drinking beverages and the risk of multiple sclerosis in Iran. M Dastoorpoor, SM Nabavi, N Majdinasab, A Zare Javid, K Ahmadi Angali, et al. Journal of Health, Population and Nutrition, 2023  Sex hormone therapy in multiple sclerosis: a systematic review of clinical trials. M Shayestehfar, M Salari, S Karimi, M Vosough, A Memari, SM Nabavi. Preprint. 2023  The Rate and Pattern of Changes in MS Disease Modifying Drugs in Tehran, Iran; a Cross-Sectional Study from Tehran MS Registry. S Eskandarieh, Z Salehi, A Ebrahimitirtashi, N Abbasi, F Khodaie, E Madreseh, SM Nabavi, et al. Multiple Sclerosis and Related Disorders, 2023  Rate of Parental Consanguineous Marriage Among Familial Multiple Sclerosis Patients in Iran: A National Registry-Based Study. S Eskandarieh, Z Salehi, F Ashtari, SM Baghbanian, SM Nabavi, et al. Multiple Sclerosis and Related Disorders, 2023  What Effects Can Expressive Writing Have on Sexual Dysfunction in Women with Multiple Sclerosis? A Randomized Controlled Trial. B Afshar, L Amini, SM Nabavi, M Hasani, M Mohammadnoori, S Jahanfar, et al. Acta Neurologica Scandinavica, 2023  Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics. F Ghadiri, MA Sahraian, N Razazian, F Ashtari, M Poursadeghfard, SM Nabavi, et al.Multiple sclerosis and related disorders, 2023  Overview on Incorporating Computer-Aided Diagnosis Systems for Dementia: Early Detection of Alzheimer's Disease. V Karami, G Nittari, S Karami, SM Nabavi. Exploring Future Opportunities of Brain-Inspired Artificial Intelligence, 2023  Effect of MS14® on physical activity of multiple sclerosis patients: A randomized triple-blind placebo-controlled clinical trial. H Rezaeizadeh, K Gharegozli, SM Nabavi, V Shayegannejad, et al. Multiple Sclerosis and Related Disorders, 2023  Biological Features of CD5+ CD19+ B1 Cell and Natural IgM (VH4-34) in Chronic Lymphocytic Leukemia vs. Multiple Sclerosis. S Pezeshki, MH Jazayeri, B Chahardouli, N Tajik, SM Nabavi, et al. Iranian Journal of Allergy, Asthma and Immunology, 2022  The Comparable Effect of tDCS and Core Exercises on Balance and Mobility in Patients With Multiple Sclerosis  S Mohammadkhanbeigi, Y Moghadas Tabrizi, SM Nabavi, H Minoonejad. Iranian Rehabilitation Journal, 2022  Prediction of Multiple Sclerosis Lesion Evolution Patterns in Brain MR Images Using Weekly Time Series Analysis. F Jamee, RM Khayati, CRG Guttmann, F Cotton, SM Nabavi. Journal of Medical and Biological Engineering, 2022  A randomized, double-blind controlled clinical study to determine the effectiveness, safety and tolerability of actoferon (R) compared to betaferon (R) in subjects with relapsing remitting multiple sclerosis (RRMS). SM Nabavi, R Abolfazli, S Shabani, A Etemadrezaei, H Hosseini, et al. MULTIPLE SCLEROSIS JOURNAL, 2022  Synchronizing victim evacuation and debris removal: A data-driven robust prediction approach. SM Nabavi, B Vahdani, BA Nadjafi, MA Adibi. European Journal of Operational Research, 2022  Advanced therapeutic medicinal products (ATMPs) in Ischemic Stroke; novel therapeutic modalities from financial perspective. S Ghashghaei, MA Mousavi, S Karimi, SS Nadali Pour, SM Nabavi, et al. Modern Medical Laboratory Journal, 2022  P38 initiates degeneration of midbrain GABAergic and glutamatergic neurons in diabetes models. A Farhadi, M Totonchi, SM Nabavi, H Baharvand, H Pakdaman, et al. European Journal of Neuroscience, 2022  Perfusion MRI in automatic classification of multiple sclerosis lesion subtypes. E Homayouny, RM Khayati, SM Nabavi, V Karami. IET Signal Processing, 2022  رترثؤم ی ن سنج درکلمع للاتخا و درکلمع رد تلاخادم ی تلوم اب دارفا ی لپ زورلکسا ی س : ی ک س رورم ی تامتس ی ک لانآاتم و ی ز . B Afshar, L Amini, M Hasani, S Jahanfar, SM Nabavi. International Journal of Reproductive BioMedicine,2022  Evaluation the Effect of the Health Promoting Lifestyle by Multimedia Education on Sexual Function in Women With Multiple Sclerosis. M Kheirkhah, A Ahadi, SM Nabavi, N Tavakkol, T Lotfi. Iran Journal of Nursing, 2022  The most effective sexual function and dysfunction interventions in individuals with multiple sclerosis: A systematic review and meta analysis. B Afshar, L Amini, M Hasani, S Jahanfar, SM Nabavi. International Journal of Reproductive BioMedicine, 2022  Tau nuclear translocation is a leading step in tau pathology process through P53 stabilization and nucleolar dispersion  S Roqanian, S Ahmadian, SM Nabavi, H Pakdaman, M Shafiezadeh, et al. Journal of Neuroscience Research, 2022  Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis. R Abolfazli, SM Nabavi, A Azimi, M Nahayati, K Gharegozli, M Ghazaeian, et al. Multiple Sclerosis and Related Disorders, 2022  The effect of sexual health promotion package on sexual life in women with multiple sclerosis: Designed based on the results of a mixed method study. V Ghasemi, SM Nabavi, M Simbar, G Ozgoli, H Alavi Majd, MS Mirshafaei, et al. Sexuality and Disability, 2022  COVID-19 vaccination willingness and acceptability in multiple sclerosis patients: a cross sectional study in Iran. SM Nabavi, M Mehrabani, L Ghalichi, MA Nahayati, M Ghaffari, F Ashtari, et al. Vaccines, 2022  The frequencies of peripheral blood CD5+CD19+ B cells, CD3−CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder. L Khani, MH Jazayeri, R Nedaeinia, M Bozorgmehr, SM Nabavi, GA Fern. Allergy, Asthma & Clinical Immunology, 2022  COVID-19 vaccination in patients with Multiple Sclerosis: A Practical guide for Neurologists. SM Nabavi, M Mehrabani, S Karimi, E Mohammadianinejad, M Ghafari, et al. Modern Medical Laboratory Journal, 2022  Safety of BBIBP-CorV (Sinopharm) COVID-19 Vaccination in People with Multiple Sclerosis: A Report From Iran. SM Nabavi, M Mehrabani, L Ghalichi, MA Nahayati, M Ghaffari, F Ashtari, et al. International Journal of Infection Prevention, 2022  COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients. SM Nabavi, M Mehrabani, L Ghalichi, MA Nahayati, M Ghaffari, F Ashtari, et al. Vaccines, 2022  Safety and efficacy of allogeneic adipose tissue mesenchymal stromal cells in amyotrophic lateral sclerosis patients, Single-center, Prospective, Open-label, Single-arm, clinical trial, long-term follow-up. SM Nabavi, SK Karimi, L Arab, L Sanjari, S Mardpour, V Azimian, et al. Cell Journal (Yakhteh), 2021  Prevalence of sexual dysfunction and related risk factors in men with multiple sclerosis in Iran: a multicenter study. SM Nabavi, M Dastoorpoor, N Majdinasab, N Khodadadi, N Khanjani, et al. Neurology and Therapy, 2021  Prevalence of sexual dysfunction in men with multiple sclerosis: a systematic review and meta-analysis. M Dastoorpoor, M Zamanian, R Moradzadeh, SM Nabavi, R Kousari. Systematic Reviews, 2021  Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. A Uccelli, A Laroni, R Ali, MA Battaglia, M Blinkenberg, L Brundin, M Clanet, O Fernandez, J Marriott, P Muraro, SM Nabavi, et al. The Lancet Neurology, 2021  Investigating the effect of expressive writing on level of sexual dysfunction in irainian women with multiple sclerosis: a randomized controlled trial. SM Nabavi, B Afshar, L Amini. MULTIPLE SCLEROSIS JOURNAL, 2021  Patient reported outcomes of new brand-generic product of Teriflunomide (TEBAZIO®) in patients with relapsing-remitting multiple sclerosis: Preliminary analysis. R Abolfazli, SM Nabavi, AR Azimi, MA Nahayati, K Gharegozli, et al. Journal of the Neurological Sciences, 2021  The interplay of tau protein and β-amyloid: while tauopathy spreads more profoundly than amyloidopathy, both processes are almost equally pathogenic. M Pourhamzeh, MT Joghataei, S Mehrabi, R Ahadi, SMM Hojjati, N Fazli, SM Nabavi, et al. Cellular and molecular neurobiology, 2021  Sexual Support for Iranian Women with Multiple Sclerosis During Treatment Process: Sufficient or Insufficient?. V Ghasemi, M Simbar, SM Nabavi, G Ozgoli, HA Majd. International Journal of MS Care, 2021  α‐synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease. F Hadi, H Akrami, M Totonchi, A Barzegar, SM Nabavi, K Shahpasand. Journal of Neurochemistry, 2021  Effect of expressive writing on promotion of body image in women with multiple sclerosis: A randomized controlled trial. B Afshar, L Amini, SM Nabavi, M Mohammadnouri, S Jahanfar, M Hasani. Journal of Mazandaran University of Medical Sciences, 2021  Identification of Multiple Sclerosis lesion subtypes and their quantitative assessments with EDSS using neuroimaging. V Karami, R Mahdavifar, A Habibzadeh, SM Nabavi. Network Modeling Analysis in Health Informatics and Bioinformatics, 2020  Sexual life under the shadow of multiple sclerosis in women: a qualitative study in Iran. V Ghasemi, M Simbar, G Ozgoli, SM Nabavi, H Alavi Majd. Sexuality and Disability, 2020  A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS). SM Khaligh Razavi, M Sadeghi, M Khanbagi, C Kalafatis, SM Nabavi. BMC neurology, 2020  Vegf and tnf-α responses to acute and chronic aerobic exercise in the patients with multiple sclerosis. S Rezaee, S Kahrizi, SM Nabavi, M Hedayati. Asian Journal of Sports Medicine, 2020  Types of pharmaceutical intervention in patients with Multiple sclerosis (MS): A fine line between immunosuppressive and risk of COVID-19 infection. M Sadeghi, A Kanani, E Barouti, SM Nabavi. Multiple sclerosis (MS), 2020  P38 Initiates Diabetic Neurodegeneration Through Glutamatergic and GABAergic Neurons. A Farhadi, M Totonchi, SM Nabavi, H Baharvand, H Pakdaman, et al. Preprint, 2020  The effectiveness of occupational therapy-based sleep interventions on quality of life and fatigue in patients with multiple sclerosis: a pilot randomized clinical trial study. M Akbarfahimi, SM Nabavi, B Kor, L Rezaie, E Paschall. Neuropsychiatric disease and treatment, 2020  Assessment of cryptochrome gene expression in multiple sclerosis patients. S Bayat, SA Sajedi, S Nabavi. EUROPEAN JOURNAL OF NEUROLOGY, 2020  Is there relationship between sexual dysfunction and body image of women with multiple sclerosis? A cross sectional study. B Afshar, L Amini, SM Nabavi, M Hasani. EUROPEAN JOURNAL OF NEUROLOGY, 2020  The Effects of Core Stability Exercises and Transcranial Direct Current Stimulation of brain on balance, walking capacity and quality of life in women with Multiple Sclerosis. SM Beigi, YM Tabrizi, SM Nabavi. EUROPEAN JOURNAL OF NEUROLOGY, 2020  The relationship between quality of life and sexual dysfunction in women with multiple sclerosis; a cross sectional study. L Amini, B Afshar, M Hasani, SM Nabavi, G Ghaedi. EUROPEAN JOURNAL OF NEUROLOGY, 2020  Improvement of sexual satisfaction in multiple sclerosis; a systematic review. B Afshar, M Hasani, L Amini, SM Nabavi. EUROPEAN JOURNAL OF NEUROLOGY, 2020  MEsenchymal StEm cells for Multiple Sclerosis (MESEMS) study: Results from a multi-center, randomized, double blind, cross-over phase 2 clinical trial with autologous Mesenchymal Stem Cells (MSC) for the therapy of multiple sclerosis. A Uccelli, A Laroni, L Brundin, M Clanet, O Fernandez, SM Nabavi, et al. European journal of neurology, 2020  Prevalence, dimensions, and predictor factors of sexual dysfunction in women of Iran Multiple Sclerosis Society: A cross-sectional study. V Ghasemi, M Simbar, G Ozgoli, SM Nabavi, H Alavi Majd. Neurological Sciences, 2020  Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities. F Foolad, F Khodagholi, SM Nabavi, M Javan. Plos one, 2020  Pregnancy and motherhood concerns surrounding women with multiple sclerosis: a qualitative content analysis. F Ghafoori, N Dehghan-Nayeri, Z Khakbazan, M Hedayatnejad, SM Nabavi. International journal of community based nursing and midwifery, 2020  MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): A randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis. A Uccelli, A Laroni, L Brundin, M Clanet, O Fernandez, SM Nabavi, et al. Trials, 2019  Using ICA-an artificial intelligence (AI)-assisted technology-as a digital biomarker of MS disease progression and treatment efficacy. SM Khaligh-Razavi, M Sadeghi, M Khanbagi, C Kalafatis, SM Nabavi. MULTIPLE SCLEROSIS JOURNAL, 2019  Effect of endurance training on serum brain-derived neurotrophic factor (BDNF) response in multiple sclerosis. SM Nabavi, S Rezaee, S Kahrizi, M Hedayati. MULTIPLE SCLEROSIS JOURNAL, 2019  Mesenchymal stem cells for multiple sclerosis (MESEMS): a multi center, randomized, double blind, cross-over phase 2 clinical trial with autologous mesenchymal stem cells (MSC). A Uccelli, A Laroni, L Brundin, M Clanet, O Fernandez, SM Nabavi, et al. MULTIPLE SCLEROSIS JOURNAL, 2019  Virtual reality (VR)-based cognitive rehabilitation: cognitive games are complementary to physical training for an optimum rehabilitation strategy in patients with multiple sclerosis (MS). M Sadeghi, M Daemi, SM Khaligh-Razavi, SM Tabasi, M Khanbagi, SM Nabavi, et al. MULTIPLE SCLEROSIS JOURNAL, 2019  Intravenous transplantation of autologous bone marrow derived mesenchymal stromal cell (BM-MSCs) in patients with multiple sclerosis, a phase I/II, double blinded, randomized cross clinical trial. SM Nabavi. Multiple sclerosis journal, 2019  The prevalence of sexual dysfunction in Iranian women with multiple sclerosis: a systematic review and meta-analysis. V Ghasemi, M Simbar, G Ozgoli, SM Nabavi, HA Majd, BM Souri, et al. Shiraz E-Medical Journal, 2019  دماراکدوخ ی سنج ی پ و ی وگش یی هدننک اه ی هب لاتبم نانز رد نآ Multiple Sclerosis. مساق ی س , ی ربم لگزا , ی گ , ی ت ی , وبن ی ولع , ی م ,دجم ی افشر یی , هلجم کشزپ هدکشناد ی ناهفصا 73 ( 625 ,) 605-615 2019  Sexual self-efficacy and its predictor factors in women with multiple sclerosis. V Ghasemi, M Simbar, G Ozgoli, SM Nabavi, H Alavi Majd, MS Mirshafaei. Journal of Isfahan Medical School, 2019  Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks. M Alipour, SM Nabavi, L Arab, M Vosough, H Pakdaman, E Ehsani, et al. Molecular biology reports, 2019  Integrated cognitive assessment: Speed and accuracy of visual processing as a reliable proxy to cognitive performance. SM Khaligh-Razavi, S Habibi, M Sadeghi, H Marefat, M Khanbagi, SM Nabavi, et al. Scientific Reports, 2019  cis pT231-Tau Drives Neurodegeneration in Bipolar Disorder. R Naserkhaki, S Zamanzadeh, H Baharvand, SM Nabavi, H Pakdaman, et al. ACS Chemical Neuroscience , 2019  Frequency of CD56dim CD16+ NK Cells in Multiple Sclerosis and Neuromyelitis Optica Patients. MB Maljaei, L Khani, MH Jazayeri, M Bozorgmehr, SM Nabavi. Multiple Sclerosis Journal, 2019  Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open label phase I clinical trial. SM Nabavi, L Arab, N Jarooghi, T Bolurieh, F Abbasi, et al. Cell Joutnal (Yakhteh), 2019  A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon Ia Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran. SM Nabavi, R Abolfazli, A Etemadrezaei, H Hosseini, N Moradi, et al. Iranian Journal of Pharmaceutical Research: IJPR, 2019  Heat shock protein 70 and the risk of multiple sclerosis in the iranian population. SPC Tarzjani, SAS Fazeli, MH Sanati, SM Nabavi. Cell Journal (Yakhteh), 2019  The mediating role of ego-strength on the relationship between attachment styles and adjustment to multiple sclerosis. MA Besharat, N Kiaei, SM Nabavi, M Gholmali Lavasani, Z Kamali. Journal of psychologicalscience, 2018  A brief language-independent and self-administered computerized test for cognitive assessment in multiple sclerosis (MS). SM Khaligh-Razavi, M Sadeghi, M Khanbagi, C Kalafatis, SM Nabavi. MULTIPLE SCLEROSIS JOURNAL, 2018  Comparative Effectiveness Study in Multiple Sclerosis Patients Using Instrumental Variable Analysis. H Hosseini, MA Mansournia, SM Nabavi, AA Akhlaghi, J Gholami, et al. Archives of Iranian Medicine, 2018  The protective role of TBX21-1514T> C polymorphism in susceptibility to multiple sclerosis. F Akbarian, M Ataei, Z Salehi, M Nabavi, MH Sanati. Iranian Journal of Neurology, 2018  سررب ی گدعاق تلالاتخا ی تلوم هب لاتبم نانز رد نآ اب طبترم لماوع و ی لپ زورلکسا ی س . دابآرز ی روپ ما , ی ن ی , وبن ی ناقح , .ی هلجم امام ،نانز یی ازان و یی ناریا 2018  Comparison of Color Vision in Patients with Multiple Sclerosis. E Mohammadi, M Akbar Fahimi, SM Nabavi, E Jafarzadehpur, AA Yekta, et al. Journal of Paramedical Sciences & Rehabilitation, 2018  Prevalence of Restless Legs Syndrome and Its Related Factors in Patients with Multiple Sclerosis. N Izadi, M Malek, M Nabavi. Journal of Mazandaran University of Medical Sciences, 2018  يسررب لپیتلوم نارامیب رد نآ اب طبترم لماوع و رارق يب ياهاپ مردنس عویش سیزورلكسا . يدزیا كلم ,نینزان , دوعسم ديس ,يوبن , . Journal of Mazandaran University of Medical Sciences (JMUMS), 2018  سررب ی ش ی عو اهاپ مردنس ی ب ی ب رد نآ اب طبترم لماوع و رارق ی نارام تلوم ی لپ زورلکسا ی س . ا ی دز ی , نزان ی ن ,کلم , وبن ی . هاگشناد کشزپ مولع ی ناردنزام 2018  Translation, cross-cultural adaptation and validation of the Persian version of COOP/WONCA charts in Persian-speaking Iranians with multiple sclerosis. M Taghipour, M Salavati, SM Nabavi, B Akhbari, I Ebrahimi Takamjani, et al. Disability and Rehabilitation, 2018  Tau immunotherapy: Hopes and hindrances. K Shahpasand, A Sepehri Shamloo, SM Nabavi, K Ping Lu, X Zhen Zhou. Human Vaccines & Immunotherapeutics , 2018  The effect of psychoeducation intervention on the quality of life, mental health, and mindfulness in patients with multiple sclerosis. MA Besharat, S Geranmayehpour, M Nabavi, F Tavalaeyan. Research in Clinical Psychology and Counseling, 2018  Elavated CSF Concentration of Macrophage Inflammatory Protein 1α and β in Relapse Remitting Multiple Sclerosis Patients. M Ebrahimi, F Alsahebfosol, M Sanjadi, S Eshaghi, M Behjati, M Etemadifar, SM Nabavi. Iranian Journal of Allergy, Asthma & Immunology, 2018  Menstrual disorders and related factors in women with multiple sclerosis. S Zarabadipour, L Amini, SM Nabavi, H Haghani. Iranian Journal of Obstetrics, Gynecology and Infertility, 2018  The Influence of Ex-PLISSIT (Extended Permission, Limited Information, Specific Suggestions, Intensive Therapy) Model on Intimacy and Sexuality of Married Women with Multiple Sclerosis. F Daneshfar, Z Behboodi-Moghadam, Z Khakbazan, SM Nabavi, et al. Sexuality and Disability, 2017  Quantitative MRI Texture Analysis of Enhancing and Non enhancing T1-hypointense Lesions without Application of Contrast Agent in Multiple Sclerosis. AA Ardakani, SM Nabavi, A Farzan, BK Najafabad. Česká a slovenská neurologie a neurochirurgie, 2017  Quantitative MRI Texture Analysis in Differentiating Enhancing and Non-enhancing T1-hypointense Lesions without Application of Contrast Agent in Multiple Sclerosis. AA Ardakani, SM Nabavi, A Farzan, BK Najafabad. Česká a Slovenská Neurologie a Neurochirurgie, 2017  Multiple sclerosis and environmental risk factors: a case-control study in Iran. M Abbasi, SM Nabavi, SM Fereshtehnejad, NZ Jou, I Ansari, et al. Neurological Sciences, 2017  Safety and efficacy of botulinum toxin a in MS patients with intractable chronic migraine. AE Eftekhari, S Kazemian, SM Nabavi, L Faghani. Journal of the Neurological Sciences, 2017  Comparison of Health-Related Quality of Life in Patients With Various Types of Multiple Sclerosis. V Maroof, M Salavati, Z Mosallanejhad, SM Nabavi. Physical Treatments-Specific Physical Therapy Journal, 2017  Safety and efficacy of botulinum toxin A in MS patients with intractable chronic migraine. S Kazemian, AE Eftekhari, SM Nabavi. MULTIPLE SCLEROSIS JOURNAL, 2017  Quantitative MRI texture analysis of enhancing and non-enhancing T1-hypointense lesions without application of contrast agent in multiple sclerosis. SM Nabavi, AA Ardakani, A Farzan, BK Najafabad. MULTIPLE SCLEROSIS JOURNAL, 2017  Identification of miR-24 and miR-137 as novel candidate multiple sclerosis miRNA biomarkers using multi-staged data analysis protocol. F Ehya, HA Tehrani, M Garshasbi, SM Nabavi. Molecular biology research communications, 2017  Low dose aspirin for MS-related fatigue: Results of a pilot, double blind, randomized trial. M Sadeghi-Naini, GG Esslami, S Fayyazi, SM Nabavi, D Morsali, et al. Neurology, Psychiatry and Brain Research, 2017  In Silico Perspectives on the Prediction of the PLP’s Epitopes involved in Multiple Sclerosis. Z Zamanzadeh, M Ataei, SM Nabavi, G Ahangari, M Sadeghi, MH Sanati. Iranian Journal of Biotechnology, 2017  Fingolimod versus high dose interferon beta-1a in multiple sclerosis: a randomized clinical trial. M Etemadifar, P Moeini, SM Nabavi. Caspian Journal of Neurological Sciences, 2017  Interference effect of prior explicit information on motor sequence learning in relapsing-remitting multiple sclerosis patients. N Zahiri, I Abollahi, SM Nabavi, F Ehsani, AM Arab, I Shaw, A Shariat, et al. The Malaysian journal of medical sciences: MJMS, 2017  Sexual dysfunction levels in iranian women suffering from multiple sclerosis. N Dehghan-Nayeri, Z Khakbazan, F Ghafoori, SM Nabavi. Multiple sclerosis and related disorders, 2017  ثأت ی ر رمت ی ن اه ی فورون ی کبد گتسخ ،لداعت رب ی ک و ی ف ی ت گدنز ی ب ی نارام تلام هب لاتبم ی لپ زورلکسا ی س . ربت سدقم ی ز ی بجر , ی زبس , ی د ی جز ی ناک ,نارماک , وبن ی متسر , ی . لصف شهوژپ همان اه ی دربراک ی تخانشناور ی . 2017  The effects of Neurofeedback training on balance, fatigue and quality of life in patients with multiple sclerosis. Y Moghadas Tabrizi, R Rajabi, K Sabzi Dizajyekan, SM Nabavi, R Rostami. Journal of Applied Psychological Research, 2017  Mindfulness-based stress reduction (MBSR) program: The effect of a novel psycho-interventional method on quality of life, mental health, and self-efficacy in female patients with multiple sclerosis: A randomized clinical trial. M Besharat, SM Nabavi, S Geranmayepour, D Morsali, S Haghani. J Biol Today’s World, 2017  Expression Alternations of CCR5 in New Case and Treated Patients with Multiple Sclerosis. S Bayat, M Ataei, SM Nabavi, M Ghahari, MH Sanati. Advanced Studies in Biology, 2017  Stroke Due to Hypercoagulable State Can Mimic Multiple Sclerosis: A Case Report. N Zahra, S Alireza, SM Nabavi, M Damineh, HS Farhad, et al. World Journal of Neuroscience, 2017  A NOVEL METHOD FOR AUTOMATIC CLASSIFICATION OF MULTIPLE SCLEROSIS LESION SUBTYPES USING DIFFUSION TENSOR MR IMAGE. Tadayon, Mahdavi Far, karami, SM nabavi. Biomedical Engineering: Applications, Basis and Communications, 2016  Risk factors of Multiple sclerosis and their Relation with Disease Severity: A Cross-sectional Study from Iran. M Abbasi, SM Nabavi, SM Fereshtehnejad, I Ansari, N Zerafatjou, et al. Archives of Iranian medicine, 2016  Association assessment between diffusion tensor magnetic resonance imaging indices and clinical disabilities in ms patients. V Karami, RM Khayati, SM Nabavi. Biomedical Engineering: Applications, Basis and Communications, 2016  Association of new putative epitopes of myelin proteolipid protein (58-74) with pathogenesis of multiple sclerosis. Z Zamanzadeh, G Ahangari, M Ataei, S Pouragahi, SM Nabavi, et al. Iranian Journal of Allergy, Asthma and Immunology, 2016  A novel method for automatic classification of multiple sclerosis lesion subtypes using diffusion tensor MR images. E Tadayon, RM Khayati, V Karami, SM Nabavi. Biomedical Engineering: Applications, Basis and Communications, 2016  Relationship between disability severity and activity of daily living in people with multiple sclerosis. M Mousai, A Hassani-Mehraban, M Akbarfahimi, SM Nabavi. Journal of Modern Rehabilitation, 2016  A combined exercise model for improving muscle strength, balance, walking distance, and motor agility in multiple sclerosis patients: A randomized clinical trial. B Sangelaji, M Kordi, F Banihashemi, SM Nabavi, S Khodadadeh, et al. Iranian journal of neurology, 2016  The effectiveness of the Permission, Limited Information, Specific suggestions, Intensive Therapy (PLISSIT) model based sexual counseling on the sexual function of women with Multiple Sclerosis who are sexually active. Z Khakbazan, F Daneshfar, Z Behboodi Moghadam, SM Nabavi, et al. Multiple sclerosis and related disorders, 2016  Correlation between cognitive functions, fatigue, depression and disability status in a cohort of multiple sclerosis patients. SM Nabavi, S Tahbaz, A Salahesh, Z Behjati, F Nourbala, S Sadeghi, et al. World Journal of Neuroscience, 2016  Polymorphisms in the Apolipoprotein E Region and Severity of Multiple Sclerosis. V Hadavi, DD Farhud, MH Sanati, SM Nabavi, M Seyedian, M Hushmand, et al. Iranian Journal of Medical Sciences, 2015  Multiple sclerosis and environmental risk factors: a case-control study in Iran. SM Nabavi, M Abbasi, N Zerafatjou, SM Fereshtenejad. EUROPEAN JOURNAL OF NEUROLOGY, 2015  Translation and validation of the COOP/WONCA functional health status charts in Farsi–speaking Iranians with multiple sclerosis. M Taghipour, M Salavati, SM Nabavi, F Rajabzadeh. European Journal of Neurology, 2015  Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients. SM Nabavi, B Sangelaji. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2015  Significant Association between Myelin Proteolipid Protein (58-74) Putative Epitope and Multiple Sclerosis Pathogenesis. M Sadeghi, S Pouragahi, Z Zamanzadeh, M Ataei, SM Nabavi, MH Sanati, et al. Seminar, 2015  Psychometric properties of the Persian version of the Fatigue Impact Scale (FIS-P) in patients with Multiple Sclerosis. M Heidari, SM Nabavi, M Akbarfahim, M Salehi, M Torabi-Nami. Iranian Rehabilitation Journal, 2015  Can hand dexterity predict the disability status of patients with multiple sclerosis?. MG Dezfuli, M Akbarfahimi, SM Nabavi, AH Mehraban, E Jafarzadehpur. Medical journal of the Islamic Republic of Iran, 2015  The effect of exercise therapy on cognitive functions in multiple sclerosis patients: A pilot study. B Sangelaji, F Estebsari, SM Nabavi, E Jamshidi, D Morsali, et al. Medical journal of the Islamic Republic of Iran, 2015  NMO and NMOSD: clinical, imaging. Laboratory and CSF characteristics: a cohort from Iran. SM Nabavi, S Fayyazi, GG Eslami, SH Aghamiri, SH Fouladizadeh, et al. MULTIPLE SCLEROSIS JOURNAL, 2014  Safety and efficacy of intravenous injection of autologous bone marrow derived mesenchymal stem cell in patients with multiple sclerosis, a double blind randomized semi cross over clinical trial: Preliminary report 1: safety issues. SM Nabavi, N Aghdami, L Arab. MULTIPLE SCLEROSIS JOURNAL, 2014  Effect of combination exercise therapy on walking distance, postural balance, fatigue and quality of life in multiple sclerosis patients: a clinical trial study. B Sangelaji, SM Nabavi, F Estebsari, MR Banshi, H Rashidian, et al. Iranian Red Crescent Medical Journal, 2014  NMO and NMOSD: clinical presentation, imaging, CSF, laboratory abnormalities and outcome in 50 patients. SM Nabavi, S Fayyazi, GG Eslami, SH Fouladizadeh. JOURNAL OF NEUROLOGY, 2014  سررب ی اور یی اپ و ی ا یی سراپ هخسن ی قم ی سا ثأت ی ر گتسخ ی . ح ی رد ی هفربکا , ی م ی ,تحلام , حلاص ی ,دوعسم , وبن ی س , ي د دوعسم . شموک. 2014  The association between urinary disorder, hypertonia and assistive device usage with falling in individual with Multiple Sclerosis. Mahsa Kosari Nejad, Shohreh Noorizadeh Dehkordi, Mehdi Dadgoo, Afsoon Hassani Mehraban, Seyed Massood Nabavi. Physical Treatments-Specific Physical Therapy Journal, 2014  EFFECT OF COMBINATION EXERCISE THERAPY ON WALKING DISTANCE, POSTURAL BALANCE, FATIGUE AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS: A CLINICAL TRIAL STUDY. S BAHRAM, SM NABAVI, E FATEMEH, RB MOHAMMAD, R HAMIDEH, et al. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 2014  Validity and reliability of the Persian-version of fatigue impact scale in multiple sclerosis patients in Iran. M Heidari, M Akbarfahimi, M Salehi, SM Nabavi. Koomesh, 2014  The effects of 8 weeks of rebound therapy and Pilates practices on static and dynamic balances in males with multiple sclerosis. SZH Sisi, H Sadeghi, SM Nabavi. Advances in Environmental Biology, 2013  Effect and sustainability of 8-weeks rebound therapy exercise on dynamic and static balance of high school male students affected by down syndrome. N Nejadsahebi, H Sadeghi, SM Nabavi. Advances in Environmental Biology, 2013  Does/INS; exercise improve cognitive functions in multiple sclerosis? Report of a pilot study. B Sangelaji, SM Nabavi. Journal of the Neurological Sciences, 2013  Low dose aspirin for MS-related fatigue: Results of a pilot, double blind, randomized trial. SM Nabavi, M Sadeghi, MS Research Group. Journal of the Neurological Sciences, 2013  IV/INS; autologous bone marrow derived mesenchymal stem cell in multiple sclerosis, double blind randomized clinical trial: Preliminary report of safety. SM Nabavi, N Aghdami, L Arab. Journal of the Neurological Sciences, 2013  The relationship between fatigue and the severity of disability, in multiple sclerosis. M Heidary, M Akbarfahimi, SM Nabavi, M Salehi. Journal of the Neurological Sciences, 2013  Effect of 8-week rebound therapy exercise on dynamic and static balance of male students affected by down syndrome. N Nejadsahebi, H Sadeghi, SM Nabavi. Journal of the Neurological Sciences, 2013  Motor sequence learning in relapsing remitting MS patients. M Zahiri, A Abdollahi, SM Nabavi. Journal of the Neurological Sciences, 2013  Low-dose Aspirin for multiple sclerosis-related fatigue: results of a pilot, double blind, randomized trial. M Sadeghi, S Fayyazi, G Ghazizadeh, SM Nabavi, SH Fouladizadeh, et al. MULTIPLE SCLEROSIS JOURNAL, 2013  The relationship between fatigue and severity of disability in multiple sclerosis. M Heidari, M Akbarfahimi, SM Nabavi, M Salehi, MT Nami, MULTIPLE SCLEROSIS JOURNAL, 2013  Explicit motor sequence learning in relapse-remission MS patients. N Zahiri, I Abdollahi, SM Nabavi, AM A'rab. Archives of Rehabilitation, 2013  Stem Cell Therapy for Multiple Sclerosise. SM Nabavi. Cell Journal (Yakhteh), 2013  Motor sequence learning in relapsing-remitting multiple sclerosis (MS) patients. N Zahiri, I Abdollahi, AM Arab, SM Nabavi. JOURNAL OF NEUROLOGY, 2013  Safety and efficacy of intravenous injection of autologous bone marrow-derived mesenchymal stem cell in patients with multiple sclerosis: a double blind randomized semi-crossover clinical trial: preliminary report 1-safety issues. SM Nabavi, N Aghdami, L Arab, A Hamzeloo. JOURNAL OF NEUROLOGY, 2013  Does exercise improve cognitive function in multiple sclerosis? Report of a pilot study. B Sangelaji, SM Nabavi. JOURNAL OF NEUROLOGY, 2013  Sexual dysfunction and predisposing factors in women with multiple sclerosis. K Mohammadi, P Rahnama, S Moayed Mohseni, S Faghihzadeh, MA Sahraean, S Mohammadi Tabar, SM Nabavi. Payesh (Health Monitor), 2013  Prevalence and risk factors of sexual dysfunction in women with multiple sclerosis disease. P Rahnama, S Mohammaditabar, K Mohammadi-Mighanaki, S Moaiedmohseni, SM Nabavi, S Faghihzadeh, MA Sahraeyian. Payesh (Health Monitor), 2013  Sexual dysfunction and predisposing factors in women with multiple sclerosis. M Khadijeh, R Parvin, M Sakineh, F Soghrat, M Sahraean, T Shafigheh, SM Nabavi. Payesh (Health Monitor), 2013  Correlation study of SSRIs drugs in Sexual Dysfunction. M Moghadamnia, SM Nabavi, S Afshinmajd. Life, 2013  Survey validity of translation for Persian and cultural adaptation of Fatigue Impact Scale (FIS) questionnaire in multiple sclerosis patients in Iran. M Heidari, M Akbarfahimi, M Salehi, SM Nabavi. Modern Rehabilitation, 2012  Environmental air pollution and acute cerebrovascular complications: an ecologic study in Tehran, Iran. SM Nabavi, B Jafari, MS Jalali, S Nedjat, K Ashrafi, A Salahesh. International Journal of Preventive Medicine, 2012  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: A case-control study from Iran. M Mehrpour, N Najimi, SM Fereshtehnejad, FN Safa, S Mirzaeizadeh,…, SM Nabavi, et al. Perspectives in Medicine, 2012  Fatigue characteristics in multiple sclerosis patients living in the northeastern Iran (a low prevalence zone). R Jajvandyan, SM Nabavi, S Oryan, H Khani. JOURNAL OF NEUROLOGY, 2012  Fatigue characteristics in multiple sclerosis patients living in the northeastern Iran (a low prevalence zone). R Jajvandyan, SM Nabavi, S Oryan, H Khani. JOURNAL OF NEUROLOGY, 2012  Cognitive performance in a cohort of MS patients in comparison to healthy subjects: an assessment with BRB-N from Iran. S Tahbaz, SM Nabavi, Z Behjati, F Nourbala, S Sadeghi, Z Saeedi. JOURNAL OF NEUROLOGY, 2012  Comparison of self-destructive personality tendencies in MS patients and healthy subjects. S Tahbaz, SM Nabavi, N Ghorbani. JOURNAL OF NEUROLOGY, 2012  The effects of combined model of training exercise in functional indexes, fatigue, quality of life and some biomarkers of MS patients. MR Kordi, SM Nabavi, S Khodadadeh, N Maghsoodi, L Anoosheh, et al. Journal of Neurology, 2012  Correlation between cognitive dysfunction, fatigue, depression and disability status in a cohort of multiple sclerosis. SM Nabavi, S Tahbaz, Z Behjati, F Nourbala, S Sadeghi, Z Saeedi, et al. JOURNAL OF NEUROLOGY, 2012  The effects of mindfulness-based stress reduction programme on physical symptoms, quality of life, and mental health in patients with multiple sclerosis. SH Granmayeh, M Besharat, SM Nabavi, S Sadeghi, A Imani. JOURNAL OF NEUROLOGY, 2012  A double-blind, placebo-controlled, study of oral MS14, a herbal marine drug, on walking ability in multiple sclerosis patients. SM Nabavi, M Naseri, H Rezaeezadeh, K Ghareguzli, V Shayegannejad, et al. JOURNAL OF NEUROLOGY, 2012  Considering the Safety Issues Vitamin D3 Supplementation in Relapsing-Remitting Multiple Sclerosis. SM Nabavi, Z Sabet, D Morsalee, M Aminzadeh. Clinical Toxicology, 2012  اقم ی هس ارگ ی ش صخش ی ت ی رختدوخ ی ب ی سانشدوخ و ی ماجسنا ی ب رد ی نارام تلام هب لاتبم ی لپ ملاس دارفا و زورلکسا. سح زابهاط ی ن نابرق ,هداز ی , وبن ی . سانشناور ی ،رصاعم سانشناور نمجنا همانلصفود ی ا ی نار . 2012  Environmental air pollution and acute cerebrovascular complications: an ecologic study in Tehran, Iran. SM Nabavi, J Batoul, J Mozhgan Sadat, N Saharnaz, A Khosro, et al. IJPM International Journal of Preventive Medicine, 2012  IL-7R α polymorphisms in 60 Iranian multiple sclerosis patients. MA Raji, A Khosravi, MH Sanati, SM Nabavi, R Hajihoseini, A Ebrahimi, et al. Iranian Journal of Neurology, 2012  Interleukin VII Receptor Gene Polymorphism in Multiple Sclerosis Patients. M Ahmadzadeh Raji, A Khosravi, M Sanati, R Hajihoseini, A Ebrahimi, SM Nabavi. SSU_Journals, 2011  Down syndrome presenting with multiple sclerosis, thyroid dysfunction, and diabetes mellitus. Multiple autoimmune disorders in a genetic disorder. SM Nabavi, A Hamzehloo, Z Sabet. Neurosciences Journal, 2011  Down syndrome presenting with multiple sclerosis thyroid dysfunction and diabetes mellitus. Z Sabet, SM Nabavi. Neurosciences, 2011  Influence of 6-week yoga on depression and fatigue in patients with multiple sclerosis, North Khorasan, northeastern Iran. R Jajvandian, SM Nabavi, S Oryan, S Samadi, H Khani, A Nikravesh. JOURNAL OF NEUROLOGY, 2011  Comparison of self-destructive tendencies and integrative self knowledge among multiple sclerosis and healthy people. S Tahbaz Hoseinzadeh, N Ghorbani, SM Nabavi. Contemporary psychology, 2011  Reversible therapy-related dysplastic hematopoiesis following Beta Interferon Therapy in Multiple Sclerosis Patients: Report of 2 Cases. SM Nabavi, A Hamzehloo, J Shams, D Morsali. Iranian Journal of Neurology, 2011  The study of association between Interleukin-7 receptor alpha chain gene and multiple sclerosis in Iranian patients. MA Raji, SM Nabavi, A Khosravi, R Hajihoseini, A Ebrahimi, MH Sanati. EUROPEAN JOURNAL OF NEUROLOGY, 2010  Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial. M Togha, SA Karvigh, SM Nabavi, NB Moghadam, MH Harirchian, et al. Multiple Sclerosis Journal, 2010  simvastatin treatment in patients with relapsing-remitting multip sclerosis receiving interferon beta LA: double blind randoized controlled trial. SM Nabavi, S Alipour. multiple Sclerosis, 2010  Effect of self-care program based on the Orem model on the Physical dimensions of life quality of patients with multiple sclerosis. R Masoudi, I Mohammadi, SM Nabavi, F Ahmadi. J Yazd Univ Med Sci, 2010  Menstrual irregularities and related plasma hormone levels in multiple sclerosis patients treated with beta interferone. SM Nabavi, SA Koupai, MR Nejati, E Garshasbi, MR Jalali. Acta Medica Iranica, 2010  Effectiveness of applying progressive muscle relaxation technique on quality of life of patients with multiple sclerosis. S Ghafari, F Ahmadi, SM Nabavi, K Anoshirvan, R Memarian, et al. Journal of clinical nursing, 2009  A double blind, placebo-controlled, crossover study on the effect of MS14, an herbal-marine drug, on quality of life in patients with multiple sclerosis. M Naseri, A Ahmadi, K Gharegozli, SM Nabavi, S Faghihzadeh, et al. J Med Plant Res, 2009  سیزورلكسا لپیتلوم هب لاتبم نز نارامیب يگدنز تیفیكرب ينامرد بآ ریثات يسررب. SM Nabavi, S Ghaffari, F Ahmadi, A Kazemnejad. يشخبناوت. 2009  FP06-MO-05 Stroke admission and air pollution in Tehran: a cross sectional study. B Jafari, M Jalali, SM Nabavi, SN Nedjat, KH Ashrafi. Journal of the Neurological Sciences, 2009  Effects of applying hydrotherapy on quality of life in women with multiple sclerosis. S Ghaffari, F Ahmadi, SM Nabavi, A Kazem Nezhad. Archives of Rehabilitation, 2008  سیزورلكسا لپیتلوم هب لاتبم نارامیب يگتسخ رب ينامرد بآ كینكت ریثات يسررب. SM Nabavi, S Ghaffari, F Ahmadi. Journal of Mazandaran University, 2008  Effects of applying hydrotherapy on fatigue in multiple sclerosis patients. S Ghafari, F Ahmadi, SM Nabavi. Journal of Mazandaran university of medical sciences, 2008  A review of Cinnagen 24 months report. SM Nabavi. Payamems, 2008  Comparison between T2-weighted fast spin echo and fast short time inversion recovery pulse sequences in the depiction of cervical cord multiple scelerosis plaque. E Rahimian, MR Tahsini, R Abolfazli, SM Nabavi. MULTIPLE SCLEROSIS, 2008  م نارامیب يگتسخ رب ينلاضع هدنورشیپ يزاس مارآ كینكت ریثات لپیتلوم هب لاتب سیزورلكسا. SM Nabavi, F Ahmadi. درکرهش يکشزپ مولع هاگشناد هلجم. 2008  Effects of applying progressive muscle relaxation technique on depression, anxiety and stress of multiple sclerosis patients in Iran National MS Society. S Ghafari, F Ahmadi, SM Nabavi, R Memarian. Research in Medicine, 2008  Simvastatin treatment in multiple sclerosis patients receiving Avonex (R): a double-blind randomised control trial. M Togha, SM Nabavi, MH Harirchian, moghadam, N. Beladi, et al. JOURNAL OF NEUROLOGY, 2008  ،يگدرسفا رب ينلاضع هدنورشیپ يزاس مارآ كینكت ریثات يسررب سرتسا و بارطضا سیزورلكسا لپیتلوم هب لاتبم نارامیب. SM Nabavi, S Ghaffari, F Ahmadi. يکشزپ رد شهوژپ. 2008  Fully automatic segmentation of multiple sclerosis lesions in brain MR FLAIR images using adaptive mixtures method and Markov random field model. R Khayati, M Vafadust, F Towhidkhah, SM Nabavi. Computers in biology and medicine, 2008  A novel method for automatic determination of different stages of multiple sclerosis lesions in brain MR FLAIR images. R Khayati, M Vafadust, F Towhidkhah, SM Nabavi. Computerized Medical Imaging and Graphics, 2008  Effect of applying progressive muscle relaxation on depression, anxiety and stress in multiple sclerosis patients. S Ghafari, F Ahmadi, SM Nabavi, R Memarian, A Kazemnejad. Iran Research in Medical Sciences, 2008  Effect of applying hydrotherapy on fatigue in multiple sclerosis patients. G Somaiyeh, A Fazlolah, SM Nabavi. Journal of Mazandaran University of Medical Sciences, 2008  The effect of progressive muscle relaxation on depression, anxiety and stress in patients with multiple sclerosis. S Ghaffari, F Ahmadi, SM Nabavi, R Memarian. Research in Medicine, martyr Beheshti University of Medical Sciences and Health Services, 2008  Effect of relaxation on fatigue of patients with multiple sclerosis. S Ghafari, F Ahmadi, SM Nabavi, R Memarian. J Shahrekord Univ Med Sci, 2008  Effect of self-care program on Ourem method on physical dimension of quality of life of Ms patient. R Masoudi, E Mohamady, SM Nabavi. Persian. J Shahrekord Med Univ, 2008  Effect of applying progressive muscle relaxation technique on fatigue in multiple sclerosis patients. S Ghafari, F AHMADI, SM Nabavi, R Memarian, A KAZEMNEJAD JOURNAL OF SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES, 2008  Efficacy of applying hydrotherapy on fatigue in patients with Multiple Sclerosis. S Ghaffari, F Ahmadi, SM Nabavi. J Mazandaran Med Sci Uni, 2008  Review of the effect of progressive muscular relaxation technique on depression, anxiety and stress of patients with multiple sclerosis. S Ghafari, F Ahmadi, SM Nabavi, R Memarian. Research journal of the medical department of Shahid Beheshti University of Medical Sciences, 2008  Efficacy of progressive muscle relaxation on depression, stress and anxiety in patients with multiple sclerosis. S Ghaffari, F Ahmadi, SM Nabavi, R Memarian. Research Journal of Shaheed Beheshti Medical University, 2008  Survey about Impact of Water Therapy on MS Sicks Tiredness. S Ghafari, F Ahmadi, SM Nabavi. Mazandaran University of Medical Science Journal, 2008  The effect of progressive muscle relaxation technique daily living activities in patients with multiple sclerosis. S Ghaffari, F Ahmadi, SM Nabavi, R Memarian, A Kazemnejad. J Rehabilitation, 2008  The effect of Orem based self-care program on physical quality of life in multiple sclerosis patients. R MASOUDI, I Mohammadi, SM Nabavi, F AHMADI. JOURNAL OF SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES, 2008  A comparison study on latency and amplitude of auditory brainstem response and auditory middle latency response in patients with multiple sclerosis and in healthy control group aged between 20 to 50 years old. G Mohammadkhani, SM Nabavi, M Monadi, H Majidi. Iranian Journal of Otorhinolaryngology, 2007  A comparative study to measure early auditory response (ABR) and middle auditory response (MLR) waves between patients with multiple sclerosis (MS) and healthy subjects: A pilot study in a group of Iranian MS patients. SM Nabavi, M Monadi, G Mohammadkhani. EUROPEAN JOURNAL OF NEUROLOGY, 2007  Effect of Applying Progressive Muscle Relaxation Activities of Daily Living in Multiple Sclerosis Patients. S Ghaffari, F Ahmadi, SM Nabavi, R Me'marian, A Kazem-Nejad. Archives of Rehabilitation, 2007  Clinical and toxicological evaluation of MS14 natural product in patients with multiple sclerosis. M Naseri, A Ahmadi, K GHAREGOZLI, SM Nabavi, S Faghihzadeh, et al. DANESHVAR MEDICINE, 2007  The study of energy conservation techniques on fatigue in patients with Multiple sclerosis. N Rasouli, F Ahmadi, SM Nabavi, E Hajizadeh. Journal of Rehabilitation, 2007  Effect of applying progressive muscle relaxation on activities of daily living in Multiple Sclerosis patients. S Ghafari, F Ahmadi, SM Nabavi, R Memarian, A KAZEMNEJAD. ARCHIVES OF REHABILITATION (JOURNAL OF REHABILITATION), 2007  THE EFFICACY OF GINKGO-TD ON AMELIORATION OF SUBJECTIVE TINNITUS. ME YARMOHAMMADI, M NASERI, SM NABAVI, A ZANGANEH, F ZAYERI. DANESHVAR MEDICINE, 2007  ا شیپ و ينیلاب ریس ،يژولویمدیپ رد سیزورلكسا لپیتلوم يهگآ 207 هعجارم رامیب هدننك كینیلك هب MS يفطصمدیهش ناتسرامیب لاس رد نارهت ينیمخ . H Ghasemi, SM Nabavi, S Farzam. نارهت يکشزپ مولع هاگشناد يکشزپ هدکشناد هلجم. 2006  The study on prevalence of depression and personality disorders in 100 epileptic patients in Iran. SM Nabavi, E Fatah, M Noroozian, N Karamghadiri. EUROPEAN JOURNAL OF NEUROLOGY, 2006  Clinical Course and prognosis of 203 patients with MS in shahid Mostafa Khomeini Hospital, Tehran 2002. SM Nabavi, P Sh, H Ghassemi. Tehran University of Medical Sciences Journal, 2006  ب رد رشنم زورلكسا هب لاتبم نارامیب رد نآ رب رثؤم لماوع و يگتسخ نازیم يسرر ناریا. A Mohamadi, D Mehdibarzi, SM Nabavi, D MehdiBarzi, O Mohammadi. ناریا يملاسا يروهمج يکشزپ ماظن نامزاس هلجم. 2006  Effect of energy saving technique on the rate of Multiple Sclerotic fatigue. N Rasouli, F Ahmadi, SM Nabavi, E Haji-Zadeh. Archives of Rehabilitation, 2006  Quality of life in multiple sclerosis compared to the healthy population in Tehran. S Nedjat, A Montazeri, K Mohammad, R Majdzadeh, SM Nabavi, F Nedjat, et al. Iranian Journal of epidemiology, 2006  Study of effect of acupressure methods on pain in primary dysmenorrhea. ZB Aghamiri, M Vigeh, R Latifnezhead, SM Nabavi. Hayat, 2006  Effect of energy conservation techniques on fatigue in women with multiple sclerosis patients. N Rasoli, F Ahmadi, SM Nabavi, E Hajizade. Journal of Rehabilitation, 2006  The effect of keeping energy techniques on fatigue level of patients with multiple sclerosis. N Rasouli, F Ahmadi, SM Nabavi, A Hajizadeh. J rahabil res, 2006  Fatigue in multiple sclerosis: A study of fatigue and some factors influencing it in Iran. SM Nabavi, DM Barzi, A Mohammadi. Journal of Medical Council of Islamic Republic of Iran, 2006  The symptom cares in MS patients. SM Nabavi, A Iranpoor. Tehran: Teimorzadeh publication, 2006  Study of effect of acupressure methods on pain in primary dysmenorrhea. Z Aghamiri, R Latifnezhead, SM Nabavi, M Vigeh, Hayat, 2005  O An investigation of human apolipoprotein E polymorphisms in multiple sclerosis patients of Iran. V Hadavi, DD Farhud, MH Sanati, SM Nabavi, M Seyedian, M Hushmand, et al. Medical Journal of the Islamic Republic of Iran, 2005  A CLINICAL SURVEY IN DETERMINATION OF COMMON SIDE EFFECTS OF AVONEX (B IF 1A) THERAPY IN 50 IRANIAN MS PATIENTS. SM Nabavi, J Lotfi, M Ghorbani, M Naseriyeh. JOURNAL OF MEDICAL COUNCIL OF IRI, 2005  CLINICAL AND ELECTROPHYSIOLOGICAL STUDY OF CARPAL TUNNEL SYNDROME IN 70 PATIENTS. SM NABAVI, P BOZORGI. DANESHVAR MEDICINE, 2005  Fatigue in multiple sclerosis: A study of fatigue in multiple sclerosis and some influencing factors in 60 MS patients in Iran. SM Nabavi, J Lotfi, A Mohammadil. EUROPEAN JOURNAL OF NEUROLOGY, 2004  The role of the traditional Iranian medicine as a treatment of chronic headache: A case series study. M Motahri, M Fathi, M Nasseri, SM Nabavi. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 2004  Association of apolipoprotein E polymorphism with susceptibility to multiple sclerosis. V Hadavi, D Farhoud, …, SM Nabavi, et al. IRANIAN JOURNAL OF BIOTECHNOLOGY, 2004  A SURVEY ON SLEEP DISORDERS VARIETY IN STUDENT OF SHAHED UNIVERSITY. SM NABAVI, AR BOHAYRAEI. DANESHVAR MEDICINE, 2003
Membership in the boards of directors of specialized scientific associations and the boards of directors of scientific journals, membership in specialized working groups of the Ministry of Health and the Food and Drug Administration
Research projects as a collaborator, research theses for master's and professional doctorates, post-doc and fellowship courses